Louise Peltier has been appointed vice president of regulatory affairs at Immunomic Therapeutics, Inc. (ITI). ITI is a privately-held biotechnology company developing vaccines based on its LAMP technology.   Ms. Peltier has more than 30 years of experience in the regulatory space and has worked both as a consultant and in-house at PharmAthene, Northwest Biotherapeutics, Caris Life Sciences, Guilford Pharmaceuticals and Centocor, where she oversaw regulatory filings, meetings and pharmacovigilanc...